$297.000,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic complexity, quality assurance, patient care, research advancement, education, and professional development within the field of clinical biochemistry. The book provides a holistic solution by offering comprehensive insights and practical guidance to a diverse audience, contributing to the enhancement of healthcare and biomedical research. Each chapter explores the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.

Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.

  • Presents the impact of biomarkers on early detection, prognosis, and personalized treatment strategies
  • Incudes ethical and regulatory considerations surrounding biomarker use, guiding policymakers and ethicists through the complex terrain of biomarker-driven healthcare decisions
  • Highlights the clinical relevance of cancer biomarkers by showcasing real-world case studies and examples of how biomarkers have been utilized to improve cancer diagnosis, personalize treatment plans, and monitor treatment responses

1. Introduction - p. xxiii 2. Chapter 1. Introduction: navigating the landscape of cancer biomarkers - p. 1 3. Chapter 2. Understanding the role of biomarkers in cancer - p. 43 4. Chapter 3. Tools and technologies for biomarker discovery - p. 63 5. Chapter 4. Genomic biomarkers: unraveling the DNA of cancer - p. 83 6. Chapter 5. Proteomics and protein biomarkers in oncology - p. 111 7. Chapter 6. Metabolomics: metabolic signatures in cancer biomarkers - p. 127 8. Chapter 7. Biomarker validation: challenges and regulatory perspectives - p. 149 9. Chapter 8. Clinical trials and studies for biomarker evaluation - p. 177 10. Chapter 9. Early detection and diagnostic biomarkers - p. 193 11. Chapter 10. Prognostic biomarkers: predicting disease outcomes - p. 211 12. Chapter 11. Predictive biomarkers: guiding personalized cancer therapies - p. 239 13. Chapter 12. Monitoring treatment response with cancer biomarkers - p. 263 14. Chapter 13. Ethical considerations in biomarker research and application - p. 275 15. Chapter 14. Challenges and future directions in biomarker development - p. 285 16. Chapter 15. Success stories: impactful applications of cancer biomarkers - p. 297 17. Chapter 16. Shaping future diagnostics: advances and innovations in cancer biomarker science - p. 333 18. Index - p. 359

Descripcion
Descripción

The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic complexity, quality assurance, patient care, research advancement, education, and professional development within the field of clinical biochemistry. The book provides a holistic solution by offering comprehensive insights and practical guidance to a diverse audience, contributing to the enhancement of healthcare and biomedical research. Each chapter explores the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.

Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.

  • Presents the impact of biomarkers on early detection, prognosis, and personalized treatment strategies
  • Incudes ethical and regulatory considerations surrounding biomarker use, guiding policymakers and ethicists through the complex terrain of biomarker-driven healthcare decisions
  • Highlights the clinical relevance of cancer biomarkers by showcasing real-world case studies and examples of how biomarkers have been utilized to improve cancer diagnosis, personalize treatment plans, and monitor treatment responses

1. Introduction - p. xxiii 2. Chapter 1. Introduction: navigating the landscape of cancer biomarkers - p. 1 3. Chapter 2. Understanding the role of biomarkers in cancer - p. 43 4. Chapter 3. Tools and technologies for biomarker discovery - p. 63 5. Chapter 4. Genomic biomarkers: unraveling the DNA of cancer - p. 83 6. Chapter 5. Proteomics and protein biomarkers in oncology - p. 111 7. Chapter 6. Metabolomics: metabolic signatures in cancer biomarkers - p. 127 8. Chapter 7. Biomarker validation: challenges and regulatory perspectives - p. 149 9. Chapter 8. Clinical trials and studies for biomarker evaluation - p. 177 10. Chapter 9. Early detection and diagnostic biomarkers - p. 193 11. Chapter 10. Prognostic biomarkers: predicting disease outcomes - p. 211 12. Chapter 11. Predictive biomarkers: guiding personalized cancer therapies - p. 239 13. Chapter 12. Monitoring treatment response with cancer biomarkers - p. 263 14. Chapter 13. Ethical considerations in biomarker research and application - p. 275 15. Chapter 14. Challenges and future directions in biomarker development - p. 285 16. Chapter 15. Success stories: impactful applications of cancer biomarkers - p. 297 17. Chapter 16. Shaping future diagnostics: advances and innovations in cancer biomarker science - p. 333 18. Index - p. 359

Indice
Autores
Muestra
Ficha Técnica